Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiation-Sensitizing Agents | 1 | 2019 | 345 | 0.590 |
Why?
|
| Glutathione | 1 | 2019 | 582 | 0.570 |
Why?
|
| Sulfites | 2 | 2023 | 83 | 0.380 |
Why?
|
| DNA, Single-Stranded | 4 | 2023 | 360 | 0.380 |
Why?
|
| Piperazines | 1 | 2019 | 2517 | 0.320 |
Why?
|
| Herpesvirus 4, Human | 3 | 2006 | 1072 | 0.270 |
Why?
|
| Epstein-Barr Virus Infections | 3 | 2006 | 605 | 0.250 |
Why?
|
| Viral Matrix Proteins | 1 | 2006 | 197 | 0.240 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2005 | 141 | 0.230 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2023 | 95 | 0.210 |
Why?
|
| Alanine Transaminase | 1 | 2005 | 607 | 0.200 |
Why?
|
| DNA Modification Methylases | 1 | 2022 | 208 | 0.200 |
Why?
|
| DNA, Viral | 2 | 2006 | 2195 | 0.190 |
Why?
|
| Abnormalities, Radiation-Induced | 1 | 2020 | 5 | 0.180 |
Why?
|
| Ketones | 1 | 2021 | 182 | 0.180 |
Why?
|
| Furans | 1 | 2021 | 198 | 0.180 |
Why?
|
| Cytomegalovirus | 1 | 2005 | 757 | 0.180 |
Why?
|
| Uveomeningoencephalitic Syndrome | 1 | 2020 | 22 | 0.180 |
Why?
|
| Gene Library | 2 | 2023 | 1060 | 0.170 |
Why?
|
| DNA Methylation | 3 | 2023 | 4371 | 0.170 |
Why?
|
| Choroid Neoplasms | 1 | 2020 | 177 | 0.160 |
Why?
|
| Radiosurgery | 2 | 2019 | 1341 | 0.160 |
Why?
|
| X-Rays | 1 | 2019 | 306 | 0.160 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2023 | 3615 | 0.160 |
Why?
|
| Cytomegalovirus Infections | 1 | 2005 | 832 | 0.150 |
Why?
|
| Choroid | 1 | 2020 | 349 | 0.150 |
Why?
|
| Herpes Zoster | 1 | 2020 | 250 | 0.150 |
Why?
|
| DNA Nucleotidylexotransferase | 3 | 2023 | 66 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13621 | 0.140 |
Why?
|
| Radiotherapy, Conformal | 1 | 2019 | 549 | 0.130 |
Why?
|
| Fluorescein Angiography | 1 | 2020 | 1042 | 0.120 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 2 | 2019 | 1659 | 0.110 |
Why?
|
| Triazoles | 1 | 2018 | 905 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3584 | 0.100 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 4625 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2006 | 6531 | 0.090 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 13238 | 0.090 |
Why?
|
| Lymphoma | 1 | 2020 | 1898 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 16871 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 5247 | 0.090 |
Why?
|
| Oligonucleotides | 2 | 2023 | 589 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2020 | 2873 | 0.070 |
Why?
|
| Genome, Human | 1 | 2019 | 4412 | 0.070 |
Why?
|
| Callithrix | 1 | 2006 | 93 | 0.070 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2006 | 330 | 0.060 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2006 | 266 | 0.050 |
Why?
|
| Radiotherapy Dosage | 2 | 2019 | 2895 | 0.050 |
Why?
|
| Cytosine | 1 | 2022 | 213 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18110 | 0.040 |
Why?
|
| Viral Load | 2 | 2006 | 3317 | 0.040 |
Why?
|
| RNA Ligase (ATP) | 1 | 2019 | 9 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2023 | 4716 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2022 | 377 | 0.040 |
Why?
|
| Bacteriophage lambda | 1 | 2019 | 142 | 0.040 |
Why?
|
| Genomic Library | 1 | 2019 | 189 | 0.040 |
Why?
|
| Herpesvirus 3, Human | 1 | 2020 | 159 | 0.040 |
Why?
|
| Micrococcal Nuclease | 1 | 2018 | 36 | 0.040 |
Why?
|
| DNA | 2 | 2023 | 7237 | 0.040 |
Why?
|
| Azides | 1 | 2018 | 118 | 0.040 |
Why?
|
| Fundus Oculi | 1 | 2020 | 541 | 0.040 |
Why?
|
| Click Chemistry | 1 | 2018 | 95 | 0.040 |
Why?
|
| Alkynes | 1 | 2018 | 313 | 0.040 |
Why?
|
| Animals | 4 | 2022 | 167838 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2019 | 282 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 1130 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2018 | 777 | 0.030 |
Why?
|
| Copper | 1 | 2018 | 367 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2005 | 2198 | 0.030 |
Why?
|
| Base Sequence | 1 | 2006 | 12450 | 0.030 |
Why?
|
| Humans | 13 | 2023 | 759255 | 0.030 |
Why?
|
| Female | 8 | 2020 | 390240 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 17629 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 1886 | 0.030 |
Why?
|
| Movement | 1 | 2019 | 1471 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2018 | 2642 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2006 | 41935 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2006 | 9282 | 0.020 |
Why?
|
| Neoplasms | 1 | 2020 | 22019 | 0.020 |
Why?
|
| Apoptosis | 1 | 2006 | 9492 | 0.020 |
Why?
|
| Liver | 1 | 2005 | 7514 | 0.020 |
Why?
|
| Software | 1 | 2023 | 4421 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 2704 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 10181 | 0.020 |
Why?
|
| Cause of Death | 1 | 2018 | 3721 | 0.020 |
Why?
|
| Infant | 2 | 2006 | 35941 | 0.020 |
Why?
|
| Tumor Necrosis Factors | 1 | 2006 | 106 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8549 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2006 | 215 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12522 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2006 | 173 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20461 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2006 | 256 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10185 | 0.020 |
Why?
|
| Pharynx | 1 | 2006 | 432 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2005 | 310 | 0.010 |
Why?
|
| Male | 6 | 2020 | 358719 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11123 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2005 | 372 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 20031 | 0.010 |
Why?
|
| Child | 2 | 2006 | 79623 | 0.010 |
Why?
|
| Adolescent | 2 | 2006 | 87560 | 0.010 |
Why?
|
| Middle Aged | 3 | 2020 | 219653 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2020 | 80121 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2005 | 980 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10747 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2364 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2020 | 24049 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2005 | 1803 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 168617 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39216 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 2860 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2006 | 3730 | 0.010 |
Why?
|
| Adult | 2 | 2006 | 219390 | 0.010 |
Why?
|
| Mice | 1 | 2021 | 81138 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2005 | 3143 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2005 | 4546 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 58867 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14652 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 64879 | 0.010 |
Why?
|
| Cytokines | 1 | 2005 | 7346 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9590 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2006 | 26109 | 0.000 |
Why?
|
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_